130 related articles for article (PubMed ID: 7213349)
1. Inhibition of protohaem ferro-lyase by N-substituted porphyrins. Structural requirements for the inhibitory effect.
De Matteis F; Gibbs AH; Smith AG
Biochem J; 1980 Sep; 189(3):645-8. PubMed ID: 7213349
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of protohaem ferro-lyase in experimental porphyria. Isolation and partial characterization of a modified porphyrin inhibitor.
De Matteis F; Gibbs AH; Tephly TR
Biochem J; 1980 Apr; 188(1):145-52. PubMed ID: 7406876
[TBL] [Abstract][Full Text] [Related]
3. Studies on the inhibition of ferrochelatase by N-alkylated dicarboxylic porphyrins. Steric factors involved and evidence that the inhibition is reversible.
De Matteis F; Gibbs AH; Harvey C
Biochem J; 1985 Mar; 226(2):537-44. PubMed ID: 3838893
[TBL] [Abstract][Full Text] [Related]
4. Drug-induced conversion of liver haem into modified porphyrins. Evidence for two classes of products.
De Matteis F; Gibbs AH
Biochem J; 1980 Apr; 187(1):285-8. PubMed ID: 7406869
[TBL] [Abstract][Full Text] [Related]
5. Ferrochelatase-inhibitory and porphyrin-inducing properties of 3,5-diethoxycarbonyl-1, 4-dihydro-2,4,6-trimethylpyridine and its analogues in chick embryo liver cells.
Cole SP; Whitney RA; Marks GS
Mol Pharmacol; 1981 Sep; 20(2):395-403. PubMed ID: 7300820
[No Abstract] [Full Text] [Related]
6. Studies on the mechanism of experimental porphyria produced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Role of a porphyrin-like inhibitor of protohaem ferro-lyase.
Tephly TR; Gibbs AH; De Matteis F
Biochem J; 1979 Apr; 180(1):241-4. PubMed ID: 486100
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of ferrochelatase by N-methylprotoporphyrin IX is not accompanied by delta-aminolevulinic acid synthetase induction in chick embryo liver cell culture.
Cole SP; Marks GS; Oritz de Montellano PR; Kunze KL
Can J Physiol Pharmacol; 1982 Feb; 60(2):212-5. PubMed ID: 6896292
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced porphyrin biosynthesis--XIX. Potentiation of the porphyrin-inducing effects of SKF 525-A in the chick embryo liver by 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine, an antihibitor of ferrochelatase.
Cole SP; Vavasour EJ; Marks GS
Biochem Pharmacol; 1979 Dec; 28(24):0533-8. PubMed ID: 533555
[No Abstract] [Full Text] [Related]
9. Occurrence and biological properties of N-methyl protoporphyrin.
De Matteis F; Gibbs AH; Holley AE
Ann N Y Acad Sci; 1987; 514():30-40. PubMed ID: 3327433
[No Abstract] [Full Text] [Related]
10. Comparison of the effects of griseofulvin and 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on ferrochelatase activity in chick embryo liver.
Cole SP; Zelt DT; Marks GS
Mol Pharmacol; 1981 May; 19(3):477-80. PubMed ID: 7266472
[No Abstract] [Full Text] [Related]
11. Evidence for the stereoselective inhibition of chick embryo hepatic ferrochelatase by N-alkylated porphyrins.
McCluskey SA; Whitney RA; Marks GS
Mol Pharmacol; 1989 Oct; 36(4):608-14. PubMed ID: 2811858
[TBL] [Abstract][Full Text] [Related]
12. Differential inhibition of hepatic ferrochelatase by the isomers of N-ethylprotoporphyrin IX.
Ortiz de Montellano PR; Kunze KL; Cole SP; Marks GS
Biochem Biophys Res Commun; 1981 Nov; 103(2):581-6. PubMed ID: 7332558
[No Abstract] [Full Text] [Related]
13. Inhibition of hepatic ferrochelatase by the four isomers of N-methylprotoporphyrin IX.
Ortiz de Montellano PR; Kunze KL; Cole SP; Marks GS
Biochem Biophys Res Commun; 1980 Dec; 97(4):1436-42. PubMed ID: 6894236
[No Abstract] [Full Text] [Related]
14. Structural requirements in dihydropyridines for ferrochelatase inhibition and delta-aminolevulinic acid synthetase induction.
Cole SP; Marks GS
Int J Biochem; 1980; 12(5-6):989-92. PubMed ID: 7450160
[No Abstract] [Full Text] [Related]
15. Differential inhibition of hepatic ferrochelatase by regioisomers of N-butyl-, N-pentyl-, N-hexyl-, and N-isobutylprotoporphyrin IX.
McCluskey SA; Marks GS; Whitney RA; Ortiz de Montellano PR
Mol Pharmacol; 1988 Jul; 34(1):80-6. PubMed ID: 3393143
[TBL] [Abstract][Full Text] [Related]
16. Metallation of the transition-state inhibitor N-methyl mesoporphyrin by ferrochelatase: implications for the catalytic reaction mechanism.
Shipovskov S; Karlberg T; Fodje M; Hansson MD; Ferreira GC; Hansson M; Reimann CT; Al-Karadaghi S
J Mol Biol; 2005 Oct; 352(5):1081-90. PubMed ID: 16140324
[TBL] [Abstract][Full Text] [Related]
17. The use of N-methylprotoporphyrin dimethyl ester to inhibit ferrochelatase in Rhodopseudomonas sphaeroides and its effect in promoting biosynthesis of magnesium tetrapyrroles.
Houghton JD; Honeybourne CL; Smith KM; Tabba HD; Jones OT
Biochem J; 1982 Nov; 208(2):479-86. PubMed ID: 6984332
[TBL] [Abstract][Full Text] [Related]
18. Bovine ferrochelatase. Kinetic analysis of inhibition by N-methylprotoporphyrin, manganese, and heme.
Dailey HA; Fleming JE
J Biol Chem; 1983 Oct; 258(19):11453-9. PubMed ID: 6688622
[TBL] [Abstract][Full Text] [Related]
19. Interaction of free porphyrins and metalloporphyrins with mouse ferrochelatase. A model for the active site of ferrochelatase.
Dailey HA; Jones CS; Karr SW
Biochim Biophys Acta; 1989 Nov; 999(1):7-11. PubMed ID: 2804139
[TBL] [Abstract][Full Text] [Related]
20. HPLC determination of ferrochelatase activity in human liver.
Roberts RG
Biomed Chromatogr; 1987; 2(2):71-5. PubMed ID: 3506837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
